To:
(Enter e-mail address of recipient)
From:
(Enter your e-mail address)
Subject:
Comments:
(Customise the e-mail with your own comments)
  Anti-Cancer Drug Passes First Clinical Hurdle
Australian pharmaceutical company, Novogen Limited, today announced the completion of the first stage of Phase I clinica...